Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Phytochemistry ; 72(17): 2155-64, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21885074

RESUMO

Leishmaniasis is a tropical disease caused by protozoan parasites of the genus Leishmania which affects 12 million people worldwide. The discovery of drugs for the treatment of leishmaniasis is a pressing concern in global health programs. The aim of this study aim was to evaluate the leishmanicidal effect of piperine and its derivatives/analogues on Leishmania amazonensis. Our results showed that piperine and phenylamide are active against promastigotes and amastigotes in infected macrophages. Both drugs induced mitochondrial swelling, loose kinetoplast DNA, and led to loss of mitochondrial membrane potential. The promastigote cell cycle was also affected with an increase in the G1 phase cells and a decrease in the S-phase cells, respectively, after piperine and phenylamide treatment. Lipid analysis of promastigotes showed that piperine reduced triglyceride, diacylglycerol, and monoacylglycerol contents, whereas phenylamide only reduced diacylglycerol levels. Both drugs were deemed non toxic to macrophages at 50 µM as assessed by XTT (sodium 2,3,-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)-carbonyl]-2H-tetrazolium inner salt), Trypan blue exclusion, and phagocytosis assays, whereas low toxicity was noted at concentrations higher than 150 µM. None of the drugs induced nitric oxide (NO) production. By contrast, piperine reduced NO production in activated macrophages. The isobologram analysis showed that piperine and phenylamide acted synergistically on the parasites suggesting that they affect different target mechanisms. These results indicate that piperine and its phenylamide analogue are candidates for development of drugs for cutaneous leishmaniasis treatment.


Assuntos
Alcaloides/uso terapêutico , Benzodioxóis/uso terapêutico , Leishmania/efeitos dos fármacos , Leishmaniose/tratamento farmacológico , Macrófagos/efeitos dos fármacos , Fitoterapia , Piper/química , Piperidinas/uso terapêutico , Alcamidas Poli-Insaturadas/uso terapêutico , Tripanossomicidas/uso terapêutico , Alcaloides/farmacologia , Amidas/farmacologia , Amidas/uso terapêutico , Benzodioxóis/farmacologia , Ciclo Celular/efeitos dos fármacos , Frutas , Glicerídeos/metabolismo , Leishmania/crescimento & desenvolvimento , Leishmania/metabolismo , Leishmaniose/parasitologia , Leishmaniose Cutânea/tratamento farmacológico , Metabolismo dos Lipídeos/efeitos dos fármacos , Macrófagos/parasitologia , Mitocôndrias/efeitos dos fármacos , Óxido Nítrico/biossíntese , Piperidinas/farmacologia , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Alcamidas Poli-Insaturadas/farmacologia , Tripanossomicidas/farmacologia
2.
Arq. bras. med. vet. zootec ; 63(2): 495-498, abr. 2011. tab
Artigo em Inglês | LILACS | ID: lil-591145

RESUMO

Aflatoxina é uma micotoxina que promove importantes efeitos tóxicos na saúde humana e animal, mesmo quando consumida em baixas doses. A administração oral de piperina (2,25mg Kg-1) em frangos de corte, por 14 dias consecutivos, aparentemente interferiu na toxidez da aflatoxina, diminuindo os danos hepáticos e seus efeitos adversos sobre os parâmetros hematológicos característicos da aflatoxicose. Esses dados preliminares sugerem que a piperina poderia ser usada na prevenção dos efeitos tóxicos originados pela ingestão de aflatoxina.


Assuntos
Animais , Aflatoxinas/toxicidade , Intoxicação/veterinária , Galinhas/classificação , Aspergillus flavus
3.
Braz. j. med. biol. res ; 22(11): 1415-9, 1989. tab, ilus
Artigo em Inglês | LILACS | ID: lil-83148

RESUMO

The anti-inflammatory activities of new compounds (I, II, II and IV) synthesized in 30% overall yield from the abundant natural product safrole, the principal chemical constituent of the oil of sassafras (Ocotea pretiosa, Lauraceae), were determined in mice. The synthesis of these new indenyl-acetic acids (I and II) and indenyl-propionic acids (III and IV) was based on the minimal structural features of non-steroid anti-inflammatory agents of the aryl- or heteroarylcarboxylic acid group. The compounds exhibited potencies 4- to 10-fold less than that of indometacin in inhibiting carrageenan-induced hindpaw edema. In contrast, like sulindac, all the new compounds were more potent than indomethacin in antagonizing writhing pain and increased vascular permeability caused by acetic acid. The results confirm the anticipated bioisosteric relationship between these synthetic derivatives, designed as sulindac analogues, and the classical non-steroidal anti-inflammatory agent, indomethacin


Assuntos
Camundongos , Animais , Masculino , Feminino , Anti-Inflamatórios não Esteroides/farmacologia , Indometacina/biossíntese , Safrol/metabolismo , Sulindaco/análogos & derivados , Analgesia , Permeabilidade Capilar/efeitos dos fármacos , Química , Safrol/análogos & derivados , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...